Medifocus, Inc. (QB) Stock Price - MDFZF

Best deals to access real time data!
Small Cap Pro
Monthly Subscription
for only
$49.05
Canna Trader Pro
Monthly Subscription
for only
$59.99
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
Medifocus, Inc. (QB) MDFZF OTCMarkets Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.00 0.0% 0.0035 0.00 0.00 0.00 0.0035 16:22:39
Bid Price Ask Price Spread Spread % News
0.0035 0.0126 0.0091 72.22% - -
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 0.00 USD

Medifocus, Inc. (QB) Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 647.44k 184.98M $ -1.54M - - 130.73M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
9.61k $ - 0.00% - -

more financials information »

Medifocus, Inc. (QB) News

Loading Messages....

Latest MDFZF Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical MDFZF Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.00350.00350.00350.003512,2840.000.0%
1 Month0.00350.0045150.00350.00357336,9280.000.0%
3 Months0.005940.006540.0026250.004243911,780-0.00244-41.08%
6 Months0.020.02010.002250.0052551294,267-0.0165-82.5%
1 Year0.020050.0310.002250.0070472124,257-0.01655-82.54%
3 Years0.02060.05140.002250.011877960,248-0.0171-83.01%
5 Years0.090.130.002250.031142766,946-0.0865-96.11%

Medifocus, Inc. (QB) Description

Medifocus, Inc. (TSXV-MFS, OTC-MDFZF) is a leader in the use of focused microwave energy to treat cancer and other tumors. It owns two fully developed technology platforms with comprehensive US and international patent protection: (1) The Endo-thermotherapy Platform-a catheter-basis focused heat technology platform that utilizes natural body openings to deliver precise microwave thermotherapy to the diseased sites. The U.S. FDA approved Prolieve Thermodilatation System for the treatment of Benign Prostatic Hyperplasia (BPH) was developed based on the Endo-thermotherapy and is currently generating revenue, and (2) The Adaptive Phased Array (APA) Microwave Focusing Platform-invented by MIT, licensed to Medifocus, directs precisely focused microwave energy at tumor center to induce shrinkage or eradication of tumors without undue harm to surrounding tissue. The Company?s APA 1000 Breast Cancer Treatment System, developed from the APA technology platform has received approval from the U.S. FDA and Health Canada to conduct the pivotal Phase III clinical trials. The Company believes that these two technology platforms can provide the design basis for the development of multiple cancer treatment systems for surface, subsurface and deep seated localized and regional cancers.


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.